AU2003245627A1 - Kinases and phosphatases - Google Patents
Kinases and phosphatasesInfo
- Publication number
- AU2003245627A1 AU2003245627A1 AU2003245627A AU2003245627A AU2003245627A1 AU 2003245627 A1 AU2003245627 A1 AU 2003245627A1 AU 2003245627 A AU2003245627 A AU 2003245627A AU 2003245627 A AU2003245627 A AU 2003245627A AU 2003245627 A1 AU2003245627 A1 AU 2003245627A1
- Authority
- AU
- Australia
- Prior art keywords
- phosphatases
- kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39065202P | 2002-06-21 | 2002-06-21 | |
US60/390,652 | 2002-06-21 | ||
US39619602P | 2002-07-15 | 2002-07-15 | |
US60/396,196 | 2002-07-15 | ||
PCT/US2003/019660 WO2004001008A2 (en) | 2002-06-21 | 2003-06-19 | Kinases and phosphatases |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003245627A1 true AU2003245627A1 (en) | 2004-01-06 |
AU2003245627A8 AU2003245627A8 (en) | 2004-01-06 |
Family
ID=30003167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003245627A Abandoned AU2003245627A1 (en) | 2002-06-21 | 2003-06-19 | Kinases and phosphatases |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003245627A1 (en) |
WO (1) | WO2004001008A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1628675A4 (en) * | 2003-05-20 | 2008-05-07 | Univ Virginia | Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
WO2005035746A2 (en) * | 2003-10-02 | 2005-04-21 | Xantos Biomedicine Ag | Medical use of tbk-1 or of inhibitors thereof |
EP2537924B1 (en) * | 2007-03-27 | 2015-03-18 | Intrexon Corporation | MEK ligands and polynucleotides encoding mek ligands |
EP2227487A1 (en) | 2007-12-28 | 2010-09-15 | Novo Nordisk A/S | Ddr1-mediated cell purification of pancreatic endocrine cells through their progenitors |
WO2009138987A2 (en) * | 2008-05-15 | 2009-11-19 | Ben-Gurion University Of The Negev Research And Development Authority | Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders |
US8871737B2 (en) | 2010-09-22 | 2014-10-28 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
WO2013096680A1 (en) | 2011-12-22 | 2013-06-27 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
EP2828277A1 (en) | 2012-03-21 | 2015-01-28 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
-
2003
- 2003-06-19 AU AU2003245627A patent/AU2003245627A1/en not_active Abandoned
- 2003-06-19 WO PCT/US2003/019660 patent/WO2004001008A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004001008A3 (en) | 2004-06-10 |
WO2004001008A2 (en) | 2003-12-31 |
AU2003245627A8 (en) | 2004-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003253880A1 (en) | Novel kinases | |
AU2002951247A0 (en) | Compounds that interact with kinases | |
AU2003258649A1 (en) | High-density nrom-finfet | |
AU2003259749A1 (en) | 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors | |
AU2003225031A1 (en) | Eptfe-reinforced perfluoroelastomers | |
AU2003215460A1 (en) | Cancer associated protein kinases and their uses | |
AU2003238930A1 (en) | Enzymes | |
AU2003226094A1 (en) | Compounds and methods | |
AU2002362935A1 (en) | Kinases and phosphatases | |
AU2003220437A1 (en) | Thiopyrimidine and isothiazolopyrimidine kinase inhibitors | |
AU2002303258A1 (en) | Kinases and phosphatases | |
AU2003245627A1 (en) | Kinases and phosphatases | |
AU2003260787A1 (en) | Protein kinases | |
AU2003212162A1 (en) | Cancer associated protein phosphatases and their uses | |
AU2003276711A1 (en) | Ribonuclease zymogen design | |
AU2003251513A1 (en) | Rsk inhibitors and therapeutic uses thereof | |
AU2003272301A1 (en) | Carotene-specific lipase | |
AU2003287427A1 (en) | Kinases and phosphatases | |
AU2002360513A1 (en) | Kinases and phosphatases | |
AU2002303878A1 (en) | Kinases and phosphatases | |
AU2003212724A1 (en) | Composition comprising phosphate | |
AU2003262856A1 (en) | Kinases and phosphatases | |
AU2003231531A1 (en) | Kinases and phosphatases | |
AU2003245747A1 (en) | Enzymes | |
AU2002321985A1 (en) | Kinases and phosphatases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |